Director-Affiliated Entity Files to Sell $12.8M in Liquidia Stock
LQDA has more than doubled off its 52-week low of $11.85 on elevated volume (2.1× avg).
Summary
A director-affiliated entity, Canaan VIII LP, plans to sell $12.8 million in Liquidia Corp stock, extending a recent trend of significant insider distribution while the stock is near its 52-week high.
Key Events · Ownership and Investor Activity · LQDA
-
Intent to Sell $12.8 Million in Stock
Canaan VIII LP, an entity affiliated with a director, filed a Form 144 to sell 200,000 shares of common stock, valued at approximately $12.8 million.
-
Continuation of Insider Distribution
This filing follows multiple previous Form 144s from Canaan VIII LP and other insiders, contributing to a net insider selling of over $66 million in the last 90 days.
-
Selling Near 52-Week Highs
The proposed sale occurs as Liquidia's stock is trading near its 52-week high of $66.775, potentially indicating profit-taking by the affiliated entity.
Analysis · LQDA · Life Sciences
Canaan VIII LP, an entity affiliated with a director, has filed a Form 144 indicating its intent to sell an additional $12.8 million worth of Liquidia common stock. This filing continues a pattern of significant insider selling from this entity and other insiders, occurring while the stock trades near its 52-week high. The ongoing distribution by a director-affiliated entity could signal a lack of conviction at current valuations.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LQDA was trading at $63.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $11.85 to $66.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.